4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050220
Director sold 4,359 shares at $0.69 ($3,008)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ajer Jeffrey Robert Director | 2023-09-18 | Sale | −4,359 | $0.69 | $3,008 | 34,153 | D: show line 1 in the form |
| Open-market sales · 4,359 sh · avg $0.69 · $3,008 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ajer Jeffrey Robert Director | 2023-09-19 | Grant or award · Stock Option | +85,000 | 85,000 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…